Knight Therapeutics (KHTRF) 5.3000 $KHTRF
Knight Therapeutics Engages Genesys Capital Management to Assist with Business Development
Marketwire - Thu May 01, 7:04AM CDT
Knight Therapeutics Inc. ("Knight"

(TSX: GUD) announced today that Genesys Capital Management Inc. ("Genesys"

has been engaged to assist Knight with its business development efforts.
Knight Therapeutics Inc. Commences Trading on TSX
Marketwire - Tue Apr 29, 7:07AM CDT
Knight Therapeutics Inc. ("Knight"

(TSX: GUD) announced that later today its common shares will commence trading on Toronto Stock Exchange. At this same time, its common shares will be de-listed from TSX Venture Exchange.
Medicure Comments on Recent Trading Activity
Marketwire - Tue Apr 15, 1:04PM CDT
Medicure Inc. ("Medicure" or the "Company"

(TSX VENTURE: MPH)(OTCQB: MCUJF), a specialty pharmaceutical company, reports that, in view of the recent market activity in the Company's stock, the Investment Industry Regulatory Organization of Canada ("IIROC"

has contacted the Company in accordance with its usual practice.
Medicure Engages Knight Therapeutics Inc. to Provide Advisory Services
Marketwire - Mon Apr 14, 7:03AM CDT
Medicure Inc. ("Medicure" or the "Company"

(TSX VENTURE: MPH)(OTCQB: MCUJF), a specialty pharmaceutical company, today announced it has entered into an arrangement with Knight Therapeutics Inc. (TSX VENTURE: GUD), under which Knight will provide advisory services to help advance Medicure's U.S. specialty pharmaceutical business and corporate development initiatives.